Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins

Details for Australian Patent Application No. 2005247195 (hide)

Owner Dexcel Pharma Technologies Ltd

Inventors Penhasi, Adel; Gomberg, Maxim

Agent Freehills

Pub. Number AU-A-2005247195

PCT Pub. Number WO2005/115380

Priority 60/574,561 27.05.04 US; 60/590,919 26.07.04 US

Filing date 26 May 2005

Wipo publication date 8 December 2005

International Classifications

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/401 (2006.01) - Proline

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/115380 Priority application(s): WO2005/115380

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247198-Orally-administrable compositions comprising stable amorphous calcium carbonate

2005247188-A stapling device